Sehested; Maxwell

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sehested; Maxwell.The latest application filed is for "combination therapies using hdac inhibitors".

Company Profile

4.4.11

Sehested; Maxwell - Copenhagen DK
Sehested; Maxwell - kobenhavn DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination therapies using HDAC inhibitors Grant 10,799,469 - Lichenstein , et al. October 13, 2	2020-10-13
Combination Therapies Using HDAC Inhibitors App 20190216755 - Lichenstein; Henri ; et al.	2019-07-18
Combination therapies using HDAC inhibitors Grant 10,285,959 - Lichenstein , et al.	2019-05-14
6-ether/thioether-purines As Topoisomerase Ii Catalytic Inhibitors And Their Use In Therapy App 20190085017 - Jensen; Lars Hollund ; et al.	2019-03-21
6-ether/thioether-purines As Topoisomerase Ii Catalytic Inhibitors And Their Use In Therapy App 20170145046 - Jensen; Lars Hollund ; et al.	2017-05-25
Combination Therapies Using Hdac Inhibitors App 20150231096 - Lichenstein; Henri ; et al.	2015-08-20
6-ether/thioether-purines As Topoisomerase Ii Catalytic Inhibitors And Their Use In Therapy App 20140031539 - JENSEN; Lars Hollund ; et al.	2014-01-30
Novel Method Of Treatment App 20120270900 - Olesen; Uffe ; et al.	2012-10-25
Cancer treatment with topoisomerase-II inhibitor, a bis-dioxypiperazine and radiation Grant 7,906,515 - Hofland , et al. March 15, 2	2011-03-15
Methods of Treatment Employing Prolonged Continuous Infusion of Belinostat App 20110003777 - Sehested; Maxwell ; et al.	2011-01-06
6-ether/thioether-purines As Topoisomerase Ii Catalytic Inhibitors And Their Use In Therapy App 20090209535 - Jensen; Lars Hollund ; et al.	2009-08-20
Combination Therapies Using Hdac Inhibitors App 20080213399 - Lichenstein; Henri ; et al.	2008-09-04
Cancer treatment with topoisomerase-ii inhibitor, a bis-dioxypiperazine and radiation App 20070185124 - Hofland; Kenneth ; et al.	2007-08-09
Treatment of accidental extravasation of anthracyclines Grant 6,727,253 - Langer , et al. April 27, 2	2004-04-27
Treatment of accidental extravasation of anthracyclines App 20020099057 - Langer, Seppo W. ; et al.	2002-07-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.